Key findings include enhanced phosphorylation of Src, Caveolin-1, and eNOS, with the vasodilation effect being abolished by nitric oxide inhibitors
Options like Tesamorelin, CJC/Ipamorelin, and Sermorelin/Ipamorelin focus on hormone balance for long-term results, while peptides such as AOD 9604 and SLU-PP-32 directly enhance fat metabolism, endurance, and weight management
An evidence-based 2026 UK guide for students, founders, CEOs and high performers ranking every option by human proof, not marketing
They do not have any significant side effects
Others might theoretically conflict with metabolic pathways already being modulated
You can watch the programme on BBC Two at 23:35 BST on Friday 23 August